For over three decades, a highly accurate early diagnostic test for ovarian cancer has eluded physicians. Now, scientists in the Georgia Tech Integrated Cancer Research Center (ICRC) have combined ...

The innovative “fragmentomics” approach could one day allow doctors to identify cancer in patients sooner than possible today using smaller blood draws LOS ANGELES--(BUSINESS WIRE)--Researchers at ...

A new research paper featured on the cover of Volume 17, Issue 11 of Aging-US was published on October 30, 2025, titled "SAMP ...

A simple blood test analysed by artificial intelligence could revolutionise early detection of primary vitreoretinal lymphoma ...

Modern cancer detection often depends on spotting tiny abnormalities in scans, something even trained specialists can miss.

A new cfDNA-based blood test uses AI to detect bladder, prostate, and kidney cancers early, offering a faster, safer, and ...

By Kelly Peters,Special to Rice NewsAs artificial intelligence plays an increasingly prominent role in decoding DNA, tracking ...

Renovaro Inc. has announced an expanded collaboration with Nebul, a leading AI cloud infrastructure company, to enhance the early detection of cancer and other diseases. The partnership will utilize ...

The partnership will expedite the availability of Freenome's tests in markets outside the U.S, according to the company.

Proven through research, driven by innovation, and tailor-made for those seeking to lead in breast health, ScreenPoint's Transpara (R) Breast AI is trusted by radiologists and women across the globe.